MO

Mediclinic International PLCDUS Mediclinic Stock Report

Last reporting period 30 Sep, 2022

Updated —

Last price

Market cap $B

4.937

Middle

Exchange

XDUS - Boerse Duesseldorf

MO4.DU Stock Analysis

MO

Uncovered

Mediclinic International PLC is uncovered by Eyestock quantitative analysis.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

38/100

Low score

Market cap $B

4.937

Dividend yield

Shares outstanding

737.11 B

Mediclinic International Plc engages in the provision of hospital services. The firm is focused on providing specialist-orientated, multi-disciplinary services. Its segments include Switzerland, Southern Africa, and the United Arab Emirates. The firm comprises 74 hospitals, five subacute hospitals, two mental health facilities, 20 day case clinics and 20 outpatient clinics. Its Hirslanden operates 17 hospitals and four day case clinics in Switzerland with around 1900 inpatient beds; Mediclinic Southern Africa's operations included 50 hospitals (three of which in Namibia), five subacute hospitals, two mental health facilities and 14 day case clinics (four of which operated by Intercare) across South Africa, and around 8 650 inpatient beds; and Mediclinic Middle East operates seven hospitals, two day case clinics and 20 outpatient clinics with around 1 000 inpatient beds in the United Arab Emirates.

View Section: Eyestock Rating